**Abstract**

**Objective**: Neuroinflammation triggered by the stimulation of matrix metalloproteinases and the subsequent release of pro-inflammatory cytokines, as a result of oxidative stress and mitochondrial dysfunction, leads to neuronal dysfunction and is one of the probable mechanisms involved in the pathogenesis of autism spectrum disorders (ASD). The aim of the present study was to explore the ameliorative potential of resveratrol on neuroinflammation in the experimental paradigm of neuroinflammatory model of ASD in rats.

**Method:** 1M Propanoic acid (PPA)(4µl) was infused over 10 minutes into the anterior portion of the lateral ventricle to induce ASD like symptoms in rats. Resveratrol (5, 10 and 15 mg/kg) was administered starting from the 2^nd^ day of the surgery and continued upto 28^th^ day. Rats were tested for various behavioural paradigms such as social interaction, stereotypy, locomotor activity, anxiety and novelty, depression, spatial learning and memory, repetitive and pervasive behaviour between the 7th day and 28th day. In addition, biochemical tests for oxidative stress, mitochondrial complexes, TNF-α and MMP-9 were also assessed.

**Results:** Intracerebroventricular injection of propanoic acid produced neurological, sensory, behavioural, biochemical and molecular deficits which were assessed as endophenotypes of autism spectrum disorders. Continued treatment with resveratrol for four weeks restored, significantly and dose dependently, all these endophenotypes in PPA induced ASD in rats.

**Conclusion**: The major finding of the study is that resveratrol restored the core and associated symptoms of autistic phenotype by suppressing oxidative-nitrosative stress, mitochondrial dysfunction, TNF-α and MMP-9 expression in PPA induced ASD in rats. Therefore, resveratrol might serve as an adjunct potential therapeutic agent for amelioration of neurobehavioural and biochemical deficits associated with autism spectrum disorders.
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